The PRL regulatory loop might be disrupted in CKD since elevated concentrations of PRL or hyperprolactinemia are present in ∼30% of the patients in the early stages and 60–80% in the advanced stages of CKD (Lo et al., 2017; Dourado et al., 2020). This evidence concerns the gene PRL and hyperprolactinemia.